Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
POU5F1
|
ENSG00000204531.11 | POU class 5 homeobox 1 |
POU2F3
|
ENSG00000137709.5 | POU class 2 homeobox 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
POU5F1 | hg19_v2_chr6_-_31138439_31138475 | 0.32 | 7.6e-02 | Click! |
POU2F3 | hg19_v2_chr11_+_120107344_120107351 | 0.26 | 1.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_23063100 | 30.57 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr14_-_107049312 | 26.05 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
chr22_+_23154239 | 24.74 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr22_+_23089870 | 24.55 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr14_-_106552755 | 24.07 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
chr14_-_107035208 | 23.78 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
chr22_+_22764088 | 22.86 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
chr22_+_22735135 | 22.43 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr14_-_107170409 | 22.42 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr2_+_89998789 | 22.21 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr16_+_32063311 | 22.00 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
chr14_-_107211459 | 21.50 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
chr2_-_89399845 | 21.47 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr14_-_106539557 | 21.28 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
chr16_+_32077386 | 20.76 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr2_+_89975669 | 20.52 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
chr2_-_89521942 | 20.26 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr14_-_107083690 | 20.21 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr14_-_106478603 | 20.16 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
chr14_-_106791536 | 20.06 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr14_-_107078851 | 19.97 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
chr14_-_107095662 | 19.90 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
chr22_+_22550113 | 19.89 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
chr2_+_89196746 | 19.85 |
ENST00000390244.2
|
IGKV5-2
|
immunoglobulin kappa variable 5-2 |
chr22_+_23029188 | 19.82 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr2_+_89952792 | 19.82 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
chr22_+_22385332 | 19.36 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr22_+_22786288 | 19.34 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr22_+_22453093 | 19.31 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr14_-_106586656 | 19.26 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr2_-_89545079 | 19.21 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr2_-_89568263 | 19.00 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
chr2_+_90139056 | 18.94 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr14_-_106573756 | 18.85 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
chr14_-_106830057 | 18.71 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr22_+_22712087 | 18.54 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr14_-_106816253 | 18.08 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
chr2_+_90077680 | 18.00 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr14_-_106610852 | 17.91 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
chr2_+_114163945 | 17.76 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr2_+_90121477 | 17.74 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr2_-_89597542 | 17.36 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
chr2_-_89417335 | 17.35 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr16_+_33020496 | 16.89 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
chr2_-_89442621 | 16.69 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr21_+_10862622 | 16.68 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
chr7_-_142511084 | 16.68 |
ENST00000417977.2
|
TRBV30
|
T cell receptor beta variable 30 (gene/pseudogene) |
chr14_-_106733624 | 16.66 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
chr2_+_90192768 | 16.57 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr2_-_182521823 | 16.54 |
ENST00000410087.3
ENST00000409440.3 |
CERKL
|
ceramide kinase-like |
chr15_-_22473353 | 16.37 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
chr16_+_33006369 | 16.29 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
chr22_+_22516550 | 16.28 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chr22_+_23077065 | 16.27 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr22_+_23134974 | 16.14 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr14_-_106878083 | 16.11 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr2_+_89923550 | 16.07 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr22_+_23010756 | 15.95 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr14_-_107114267 | 15.87 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
chr2_+_90043607 | 15.76 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
chr2_-_89340242 | 15.74 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr2_-_89247338 | 15.69 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr2_+_90153696 | 15.68 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr2_+_90248739 | 15.68 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr14_-_106494587 | 15.64 |
ENST00000390597.2
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
chr2_-_89266286 | 15.50 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr2_+_90060377 | 15.46 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr6_-_154567984 | 14.96 |
ENST00000517438.1
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
chr16_-_33647696 | 14.84 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
chr2_+_90198535 | 14.66 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr16_+_33629600 | 14.58 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
chr14_-_106845789 | 14.43 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
chr4_-_71532207 | 14.17 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr2_+_90458201 | 14.08 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
chrX_-_48776292 | 13.83 |
ENST00000376509.4
|
PIM2
|
pim-2 oncogene |
chr2_+_89890533 | 13.44 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr16_+_23847267 | 13.36 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
chr2_+_89184868 | 13.06 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr14_+_22180536 | 12.52 |
ENST00000390424.2
|
TRAV2
|
T cell receptor alpha variable 2 |
chr4_+_40194570 | 12.32 |
ENST00000507851.1
|
RHOH
|
ras homolog family member H |
chr6_-_108145499 | 12.11 |
ENST00000369020.3
ENST00000369022.2 |
SCML4
|
sex comb on midleg-like 4 (Drosophila) |
chr14_-_107283278 | 12.03 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
chr14_-_106453155 | 11.88 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
chr2_+_89986318 | 11.64 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr6_-_32784687 | 11.50 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
chr4_-_71532339 | 11.24 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr14_-_106692191 | 11.24 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
chr2_-_89327228 | 11.13 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr14_-_106805716 | 10.95 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
chr2_+_87565634 | 10.94 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr22_+_22697537 | 10.87 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
chr2_-_89619904 | 10.77 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr2_-_89385283 | 10.51 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr15_-_22448819 | 10.48 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr2_-_90538397 | 10.31 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
chr3_+_98250743 | 10.25 |
ENST00000284311.3
|
GPR15
|
G protein-coupled receptor 15 |
chr2_-_89278535 | 10.15 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr22_+_23101182 | 10.14 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr2_+_90211643 | 10.10 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr22_+_23222886 | 10.05 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr16_+_23847339 | 10.05 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr6_-_11779403 | 9.82 |
ENST00000414691.3
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr2_+_89901292 | 9.79 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr19_+_35820064 | 9.73 |
ENST00000341773.6
ENST00000600131.1 ENST00000270311.6 ENST00000595780.1 ENST00000597916.1 ENST00000593867.1 ENST00000600424.1 ENST00000599811.1 ENST00000536635.2 ENST00000085219.5 ENST00000544992.2 ENST00000419549.2 |
CD22
|
CD22 molecule |
chr4_-_71532601 | 9.66 |
ENST00000510614.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr22_+_22707260 | 9.65 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
chr19_+_14693888 | 9.64 |
ENST00000547437.1
ENST00000397439.2 ENST00000417570.1 |
CLEC17A
|
C-type lectin domain family 17, member A |
chr1_-_206306107 | 9.53 |
ENST00000436158.1
ENST00000455672.1 |
RP11-38J22.6
|
RP11-38J22.6 |
chr2_+_90259593 | 9.48 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr14_-_106758101 | 9.40 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chr22_+_23165153 | 9.28 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr2_-_113594279 | 9.24 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr2_+_90024732 | 9.18 |
ENST00000390268.2
|
IGKV2D-26
|
immunoglobulin kappa variable 2D-26 |
chr6_+_26251835 | 9.16 |
ENST00000356350.2
|
HIST1H2BH
|
histone cluster 1, H2bh |
chr2_+_90273679 | 9.09 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr2_-_89476644 | 9.04 |
ENST00000484817.1
|
IGKV2-24
|
immunoglobulin kappa variable 2-24 |
chr2_-_89513402 | 9.03 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr22_+_23040274 | 8.96 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr14_-_106926724 | 8.89 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
chr12_-_123201337 | 8.79 |
ENST00000528880.2
|
HCAR3
|
hydroxycarboxylic acid receptor 3 |
chr14_-_106994333 | 8.76 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
chr14_-_106622419 | 8.76 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
chr7_-_3083573 | 8.71 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
chr4_-_71532668 | 8.69 |
ENST00000510437.1
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr2_-_89459813 | 8.68 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr16_+_23847355 | 8.64 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
chr14_-_106866934 | 8.61 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
chr14_-_107013465 | 8.59 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
chr6_-_128222103 | 8.58 |
ENST00000434358.1
ENST00000543064.1 ENST00000368248.2 |
THEMIS
|
thymocyte selection associated |
chr14_-_107219365 | 8.48 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
chr14_-_106518922 | 8.48 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
chr16_+_33605231 | 8.46 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
chr3_+_46395219 | 8.44 |
ENST00000445132.2
ENST00000292301.4 |
CCR2
|
chemokine (C-C motif) receptor 2 |
chr5_+_156607829 | 8.37 |
ENST00000422843.3
|
ITK
|
IL2-inducible T-cell kinase |
chr14_-_106967788 | 8.32 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr1_+_27668505 | 8.31 |
ENST00000318074.5
|
SYTL1
|
synaptotagmin-like 1 |
chr5_-_111091948 | 8.29 |
ENST00000447165.2
|
NREP
|
neuronal regeneration related protein |
chr14_+_22236722 | 8.23 |
ENST00000390428.3
|
TRAV6
|
T cell receptor alpha variable 6 |
chr22_+_23114284 | 8.21 |
ENST00000390313.2
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
chr22_-_24096562 | 8.20 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr14_-_107199464 | 8.16 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
chr19_-_39108552 | 8.14 |
ENST00000591517.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr2_+_68962014 | 8.10 |
ENST00000467265.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr22_+_23213658 | 7.93 |
ENST00000390318.2
|
IGLV4-3
|
immunoglobulin lambda variable 4-3 |
chr2_+_90229045 | 7.88 |
ENST00000390278.2
|
IGKV1D-42
|
immunoglobulin kappa variable 1D-42 (non-functional) |
chr22_-_24096630 | 7.87 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr19_-_39108568 | 7.71 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr6_-_31560729 | 7.66 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
chr4_+_71091786 | 7.52 |
ENST00000317987.5
|
FDCSP
|
follicular dendritic cell secreted protein |
chr7_-_3083472 | 7.51 |
ENST00000356408.3
|
CARD11
|
caspase recruitment domain family, member 11 |
chr13_-_99959641 | 7.32 |
ENST00000376414.4
|
GPR183
|
G protein-coupled receptor 183 |
chr14_-_107131560 | 7.29 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr14_-_106963409 | 7.28 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chr6_-_26216872 | 7.24 |
ENST00000244601.3
|
HIST1H2BG
|
histone cluster 1, H2bg |
chr3_+_46395579 | 7.19 |
ENST00000421659.1
|
CCR2
|
chemokine (C-C motif) receptor 2 |
chr15_-_20193370 | 7.04 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr5_+_54398463 | 7.00 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
chr4_+_40194609 | 6.99 |
ENST00000508513.1
|
RHOH
|
ras homolog family member H |
chr14_-_106725723 | 6.93 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr2_+_90108504 | 6.82 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr1_-_157746909 | 6.78 |
ENST00000392274.3
ENST00000361516.3 ENST00000368181.4 |
FCRL2
|
Fc receptor-like 2 |
chr14_+_22689792 | 6.78 |
ENST00000390462.1
|
TRAV35
|
T cell receptor alpha variable 35 |
chr1_-_157789850 | 6.69 |
ENST00000491942.1
ENST00000358292.3 ENST00000368176.3 |
FCRL1
|
Fc receptor-like 1 |
chr22_+_22676808 | 6.57 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr19_-_39108643 | 6.57 |
ENST00000396857.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr13_-_99910673 | 6.57 |
ENST00000397473.2
ENST00000397470.2 |
GPR18
|
G protein-coupled receptor 18 |
chr15_-_20170354 | 6.53 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
chr14_-_107179265 | 6.50 |
ENST00000390634.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
chr22_+_22930626 | 6.27 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
chr5_-_66492562 | 6.10 |
ENST00000256447.4
|
CD180
|
CD180 molecule |
chr4_-_164534657 | 6.07 |
ENST00000339875.5
|
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
chr1_-_108231101 | 6.04 |
ENST00000544443.1
ENST00000415432.2 |
VAV3
|
vav 3 guanine nucleotide exchange factor |
chr17_-_62009702 | 5.92 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr7_+_50348268 | 5.92 |
ENST00000438033.1
ENST00000439701.1 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr14_+_22739823 | 5.87 |
ENST00000390464.2
|
TRAV38-1
|
T cell receptor alpha variable 38-1 |
chr17_-_62009621 | 5.85 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr17_-_79620721 | 5.77 |
ENST00000571004.1
|
PDE6G
|
phosphodiesterase 6G, cGMP-specific, rod, gamma |
chr12_+_93115281 | 5.72 |
ENST00000549856.1
|
PLEKHG7
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 7 |
chr16_+_32859034 | 5.63 |
ENST00000567458.2
ENST00000560724.1 |
IGHV2OR16-5
|
immunoglobulin heavy variable 2/OR16-5 (non-functional) |
chr14_+_22111077 | 5.62 |
ENST00000390423.2
|
TRAV1-2
|
T cell receptor alpha variable 1-2 |
chr8_-_134114721 | 5.60 |
ENST00000522119.1
ENST00000523610.1 ENST00000521302.1 ENST00000519558.1 ENST00000519747.1 ENST00000517648.1 |
SLA
|
Src-like-adaptor |
chr12_+_93096619 | 5.57 |
ENST00000397833.3
|
C12orf74
|
chromosome 12 open reading frame 74 |
chr9_-_34691201 | 5.56 |
ENST00000378800.3
ENST00000311925.2 |
CCL19
|
chemokine (C-C motif) ligand 19 |
chr22_+_22730353 | 5.56 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr19_-_18508396 | 5.51 |
ENST00000595840.1
ENST00000339007.3 |
LRRC25
|
leucine rich repeat containing 25 |
chr16_+_31366536 | 5.50 |
ENST00000562522.1
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit) |
chr22_+_22723969 | 5.42 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
chr8_-_134114866 | 5.41 |
ENST00000524345.1
|
SLA
|
Src-like-adaptor |
chr5_-_175965008 | 5.40 |
ENST00000537487.1
|
RNF44
|
ring finger protein 44 |
chr18_-_30353025 | 5.39 |
ENST00000359358.4
|
KLHL14
|
kelch-like family member 14 |
chr17_-_73840774 | 5.36 |
ENST00000207549.4
|
UNC13D
|
unc-13 homolog D (C. elegans) |
chr14_+_22089953 | 5.34 |
ENST00000542354.1
|
TRAV1-1
|
T cell receptor alpha variable 1-1 |
chr12_-_45269430 | 5.31 |
ENST00000395487.2
|
NELL2
|
NEL-like 2 (chicken) |
chr4_+_153021899 | 5.30 |
ENST00000509332.1
ENST00000504144.1 ENST00000499452.2 |
RP11-18H21.1
|
RP11-18H21.1 |
chr9_-_35618364 | 5.29 |
ENST00000378431.1
ENST00000378430.3 ENST00000259633.4 |
CD72
|
CD72 molecule |
chr8_+_56792377 | 5.24 |
ENST00000520220.2
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chr22_+_22781853 | 5.20 |
ENST00000390300.2
|
IGLV5-37
|
immunoglobulin lambda variable 5-37 |
chr12_-_123187890 | 5.10 |
ENST00000328880.5
|
HCAR2
|
hydroxycarboxylic acid receptor 2 |
chr1_-_228645556 | 5.07 |
ENST00000366695.2
|
HIST3H2A
|
histone cluster 3, H2a |
chr22_+_22749343 | 5.04 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 32.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
7.6 | 22.9 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
6.9 | 1195.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
4.3 | 4.3 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
3.8 | 11.5 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
3.7 | 14.7 | GO:0002432 | granuloma formation(GO:0002432) |
3.4 | 13.7 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
3.4 | 10.1 | GO:0070666 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
3.1 | 9.2 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
3.0 | 15.0 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
2.6 | 7.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
2.3 | 520.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
2.0 | 8.1 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
1.9 | 5.6 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
1.5 | 6.0 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
1.5 | 5.9 | GO:2000146 | negative regulation of cell migration(GO:0030336) negative regulation of cell motility(GO:2000146) |
1.5 | 4.4 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
1.4 | 4.2 | GO:1903980 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) positive regulation of microglial cell activation(GO:1903980) |
1.3 | 4.0 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
1.0 | 8.2 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
1.0 | 4.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
1.0 | 6.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.9 | 7.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.9 | 22.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.8 | 4.2 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
0.8 | 4.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 2.4 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.7 | 8.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 4.3 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.7 | 5.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.7 | 4.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.7 | 2.7 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.7 | 2.0 | GO:1990709 | maintenance of synapse structure(GO:0099558) presynaptic active zone organization(GO:1990709) |
0.7 | 2.6 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.7 | 3.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.6 | 2.5 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.6 | 3.7 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.6 | 3.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 4.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.6 | 1.8 | GO:2000196 | positive regulation of female gonad development(GO:2000196) regulation of progesterone secretion(GO:2000870) |
0.6 | 3.5 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.6 | 1.1 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) positive regulation of hypersensitivity(GO:0002885) type I hypersensitivity(GO:0016068) |
0.6 | 9.7 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.6 | 10.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.6 | 6.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.6 | 1.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 2.8 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.5 | 2.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.5 | 3.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.5 | 3.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.5 | 1.6 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.5 | 1.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.5 | 2.1 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.5 | 8.6 | GO:0043383 | negative T cell selection(GO:0043383) |
0.5 | 1.5 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.5 | 4.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.5 | 1.0 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) regulation of tolerance induction dependent upon immune response(GO:0002652) |
0.5 | 1.5 | GO:0035283 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 3.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.5 | 3.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.5 | 1.9 | GO:0035910 | N-terminal peptidyl-lysine acetylation(GO:0018076) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.5 | 3.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.4 | 2.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 1.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.4 | 1.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 1.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.4 | 22.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.4 | 4.3 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
0.4 | 6.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 5.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 1.7 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.4 | 3.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.4 | 2.1 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.4 | 1.2 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.4 | 1.2 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.4 | 1.2 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.4 | 8.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 10.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 1.9 | GO:0072101 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.4 | 1.5 | GO:0018277 | protein deamination(GO:0018277) |
0.4 | 1.5 | GO:0052419 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.4 | 1.5 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.4 | 2.9 | GO:1902510 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) regulation of apoptotic DNA fragmentation(GO:1902510) |
0.4 | 5.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.4 | 2.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 2.8 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.3 | 4.4 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.3 | 1.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 1.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.3 | 2.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 1.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.3 | 5.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.9 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.3 | 1.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 4.3 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.3 | 1.5 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.3 | 4.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 1.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.3 | 0.9 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.3 | 27.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 0.8 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.3 | 4.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.8 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.3 | 1.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.3 | 1.8 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 1.0 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.3 | 0.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.8 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.3 | 0.8 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.3 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 1.0 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.2 | 1.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 2.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 10.2 | GO:0072678 | T cell migration(GO:0072678) |
0.2 | 2.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 0.7 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
0.2 | 1.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.2 | 1.3 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.2 | 6.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.9 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) renal water absorption(GO:0070295) |
0.2 | 1.9 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.2 | 1.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.2 | 2.5 | GO:0009304 | tRNA transcription(GO:0009304) |
0.2 | 0.8 | GO:1901963 | regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
0.2 | 6.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 4.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 3.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.6 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.2 | 9.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 1.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 3.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 17.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 1.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.7 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.2 | 3.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 1.5 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.2 | 2.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 1.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.5 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 3.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 3.3 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.2 | 1.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.2 | 0.2 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.2 | 0.3 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 2.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 2.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.9 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.3 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 0.9 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.2 | 19.2 | GO:0030183 | B cell differentiation(GO:0030183) |
0.2 | 6.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.1 | 3.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 5.4 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 2.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 1.3 | GO:1901660 | cellular response to corticosterone stimulus(GO:0071386) calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.1 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.7 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.1 | 9.6 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 2.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 1.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 6.4 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.4 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.1 | 1.6 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 2.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.4 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 3.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 1.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 12.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.6 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 10.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.4 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.1 | 1.1 | GO:0055118 | intracellular sequestering of iron ion(GO:0006880) negative regulation of cardiac muscle contraction(GO:0055118) sequestering of iron ion(GO:0097577) |
0.1 | 1.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
0.1 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 1.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 0.6 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 1.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 2.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.5 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 0.4 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.1 | 4.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 2.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.5 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.1 | 0.5 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 1.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 6.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 3.6 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 2.0 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 4.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.5 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.1 | 7.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 1.0 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 1.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 2.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.7 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 2.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 9.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 2.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 1.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.1 | 2.2 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 2.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 13.9 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.1 | 0.7 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 20.0 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 1.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.6 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 1.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 4.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 3.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.3 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 0.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.1 | 0.7 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.3 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 3.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.3 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.5 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 1.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.2 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.1 | 0.9 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 0.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 1.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 2.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 1.9 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.8 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 1.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 2.4 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.1 | 0.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.5 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.1 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.4 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.1 | 1.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.7 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 2.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.8 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.6 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.7 | GO:1901987 | regulation of cell cycle phase transition(GO:1901987) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.4 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.1 | 2.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 1.4 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 5.2 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
0.0 | 2.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 1.8 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.5 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 1.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.2 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 1.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 5.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 3.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 2.6 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.4 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 1.4 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.6 | GO:0098869 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.6 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.0 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 20.6 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.4 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 1.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.4 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 1.0 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.0 | 0.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 1.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.3 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.4 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 1.0 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.0 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 1.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 6.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.6 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 1.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 1.3 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.0 | 2.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.6 | GO:0001707 | mesoderm formation(GO:0001707) mesoderm morphogenesis(GO:0048332) |
0.0 | 0.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 1.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.9 | GO:0006024 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 2.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.9 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.3 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.8 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 1.0 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.2 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.1 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.5 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.5 | 403.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.7 | 10.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.7 | 11.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.6 | 6.5 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
1.5 | 6.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
1.0 | 225.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.8 | 14.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 15.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.7 | 2.9 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 4.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 2.5 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.6 | 2.9 | GO:1990031 | pinceau fiber(GO:1990031) |
0.6 | 43.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 3.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 7.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 1.5 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.4 | 2.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.3 | GO:0036398 | TCR signalosome(GO:0036398) |
0.4 | 2.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 13.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 1.2 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.4 | 1.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 5.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 1.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 0.7 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.3 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 0.9 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.3 | 1.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.3 | 5.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 0.3 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.3 | 19.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 2.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.4 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 5.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.2 | 514.4 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 2.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.9 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.2 | 4.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 13.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 3.7 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 1.5 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 7.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 4.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.5 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 9.4 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 1.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 5.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 1.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 1.1 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 1.1 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.2 | 35.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 4.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 9.4 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.4 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.1 | 1.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.1 | 3.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 11.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 6.8 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 8.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.5 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 3.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 11.3 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 7.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 12.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.5 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 4.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.8 | GO:0042589 | zymogen granule(GO:0042588) zymogen granule membrane(GO:0042589) |
0.1 | 1.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 2.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 3.8 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.6 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 1.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 292.4 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 5.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 3.3 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 1.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.0 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.7 | GO:0031094 | platelet dense tubular network(GO:0031094) platelet dense tubular network membrane(GO:0031095) |
0.0 | 2.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.0 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 3.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 39.1 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 2.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.7 | GO:0043596 | site of double-strand break(GO:0035861) nuclear replication fork(GO:0043596) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 32.0 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
5.9 | 386.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
5.6 | 1239.3 | GO:0003823 | antigen binding(GO:0003823) |
2.8 | 14.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.9 | 30.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.9 | 9.6 | GO:0042806 | fucose binding(GO:0042806) |
1.4 | 5.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.4 | 4.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.2 | 15.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 11.0 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
1.0 | 12.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.0 | 22.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.0 | 2.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.9 | 1.8 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.9 | 22.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.8 | 4.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.7 | 6.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.7 | 6.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 18.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 2.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.7 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.7 | 2.6 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.6 | 13.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.6 | 2.5 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.6 | 7.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.6 | 16.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 19.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 3.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 1.6 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.5 | 1.6 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.5 | 4.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 4.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 4.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 2.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.5 | 2.0 | GO:0050308 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) phosphofructokinase activity(GO:0008443) carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.5 | 2.0 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 1.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
0.5 | 3.4 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.5 | 3.3 | GO:0016160 | amylase activity(GO:0016160) |
0.5 | 1.4 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.5 | 4.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 1.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 7.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 2.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 2.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 1.2 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) polyamine binding(GO:0019808) |
0.4 | 1.2 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.4 | 8.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 2.4 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.3 | 1.7 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.3 | 7.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.0 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.3 | 35.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 2.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 3.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 2.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.3 | 2.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 3.7 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.3 | 6.1 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.8 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.3 | 8.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 1.8 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.3 | 0.8 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.2 | 1.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.2 | 7.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 6.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 1.7 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.2 | 8.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 1.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.2 | 0.6 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 1.0 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.2 | 6.0 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 0.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 6.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 9.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 1.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 1.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 1.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.4 | GO:0032427 | GBD domain binding(GO:0032427) |
0.2 | 3.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 3.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 3.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 1.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 2.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.7 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 1.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 1.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 1.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 2.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 3.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.7 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 6.7 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 4.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 6.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.5 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.1 | 1.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.4 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 2.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.6 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.1 | 0.5 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.1 | 1.2 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.1 | 1.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 2.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 2.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.0 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.1 | 1.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.3 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.1 | 0.8 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 1.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.5 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 3.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 2.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.5 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 1.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 2.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 2.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 3.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 1.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 3.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 2.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 3.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 3.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 3.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.5 | GO:0048037 | cofactor binding(GO:0048037) |
0.1 | 3.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.4 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 1.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.2 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 0.2 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.1 | 0.2 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.1 | 0.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 2.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 3.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.7 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 5.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 2.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.2 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 0.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.0 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 1.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 1.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 18.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 3.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 1.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 2.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 1.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 1.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 5.4 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 1.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 8.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.0 | 1.0 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 1.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 4.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:1990948 | 5S rRNA binding(GO:0008097) ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 3.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.7 | GO:0004871 | signal transducer activity(GO:0004871) |
0.0 | 0.1 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 1.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 1.0 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 55.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 2.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 20.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 25.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 55.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 28.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 16.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 10.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 4.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 19.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 10.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 6.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 9.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 5.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 5.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 4.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 6.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 3.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 15.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 3.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 18.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 6.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 3.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 6.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 3.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 1.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 2.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 2.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 1.2 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 5.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.9 | PID PLK1 PATHWAY | PLK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.8 | 3.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 27.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 40.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 10.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 38.7 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.4 | 23.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 8.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 11.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 4.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 6.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 14.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 4.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 7.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 4.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 5.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 9.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 10.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 1.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 22.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 9.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 7.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 13.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 4.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 29.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 5.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 4.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 28.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 3.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 4.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 9.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 3.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 6.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 5.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 3.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 3.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 4.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 6.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 2.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 6.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.8 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 1.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.4 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.5 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 2.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 1.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 1.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |